Venture-Backed Startups

Cérélia manufactures ready-to-bake dough products such as pie, pizza and pastry doughs, along with crêpes, pancakes, waffles, flatbread and cookies. It sells through its own brands, private-label and co-manufacturing partnerships across more than 50 countries, operating production sites in Europe and North America.

1 investor

Cerenion develops C-Trend, an AI-assisted software tool that converts complex EEG waveforms into quantitative EEG (qEEG) parameters and trends for real-time brain monitoring. It serves intensivists and healthcare professionals in acute and intensive care settings, and its CE-marked medical device is available in the EU but not in the USA.

1 investor

Cerenovus unifies scattered corporate data—documents, emails, spreadsheets, chat messages—into a knowledge graph that both people and AI can query, then analyzes organizational workflows to surface operational inefficiencies and recommend improvements for executive decision-making.

1 investor

Ceres is a nonprofit advocacy organization that works with investors, companies, and policymakers on sustainability issues including climate, natural ecosystems, and water management. It produces research and reports and runs networks to promote responsible action toward a cleaner, more resilient economy.

1 investor

0 investors

Ceres grows organic shiitake and oyster mushrooms year-round at its farm in Crossfield, Alberta, using agricultural byproducts as growing substrate. It supplies specialty mushrooms to retailers, distributors, and foodservice customers across Western Canada.

1 investor

0 investors

0 investors

0 investors

Ceres AI provides aerial imagery and analytics to help growers monitor crop water use, plant health, and nutrient needs, supporting targeted decisions on irrigation and fertilizer application. The service is aimed at agricultural producers and farm operations.

5 investors

Ceres Nanosciences develops Nanotrap particle technology, a magnetic hydrogel used to capture, concentrate, and preserve low-abundance analytes such as pathogens, proteins, and cell-free biomarkers from complex biological and environmental samples. Its products support sample preparation for molecular, proteomic, and culture-based workflows including PCR, sequencing, mass spectrometry, liquid biopsy, and wastewater surveillance.

0 investors

0 investors

Austin-based leadership development platform that companies buy to help early- and mid-career and underrepresented employees advance.

1 investor

Pharmaceutical company developing novel approach to Alzheimer's disease

1 investor

0 investors

CereTax is a cloud-native, AI-powered platform for indirect tax that automates sales and use tax compliance across many jurisdictions. It serves businesses in industries including telecom, SaaS, retail, manufacturing, energy, and ecommerce.

1 investor

Ceretrieve Ltd. develops neurointerventional medical devices, including distal access catheters, thrombectomy devices, and related accessories, working with physicians to improve device performance and patient outcomes. It serves the interventional physician and neurovascular care market.

1 investor

Ceretype is a services, platform, and insights company that produces functional brain maps and biomarkers by quantifying fMRI data to measure brain activity and circuitry at the individual patient level. Its cloud-based platform serves drug and device developers and clinicians working on psychiatric and neurological disorders, with initial applications in anxiety, mood disorders, and neurodegenerative disease.

2 investors

0 investors

Cereus Ultrasonics develops ultra-wideband active/passive sonar systems and high-power analogue components for interfacing piezo-electric transducers to power amplifiers in fluidic and high-pressure gas mediums. The company applies electro-acoustic techniques such as Acoustic Resonance Technology, including crack detection and condition measurement in gas pipelines.

1 investor

Cerevance is a clinical-stage drug discovery and development company developing non-dopaminergic, orally-delivered therapies for brain and central nervous system disorders, including Parkinson's disease, schizophrenia, Alzheimer's disease, and ALS. It uses a proprietary human brain tissue profiling platform (NETSseq) and advances candidates such as solengepras (CVN424), CVN293, and CVN766 through clinical trials.

5 investors

Cerevanta provides AI-powered analysis of brain imaging to help neurologists make clinical decisions more effectively. The platform targets neurology care providers to reduce diagnostic delays and improve patient outcomes.

1 investor

CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.

1 investor

0 investors